An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment

Quite a few estrogen receptor (ER)‐positive breast cancer patients receiving endocrine therapy are at risk of disease recurrence and death. ER‐related genes are involved in the progression and chemoresistance of breast cancer. In this study, we identified an ER‐related gene signature that can predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jianing, Cui, Qiuxia, Zhang, Dan, Liao, Xing, Zhu, Jian, Wu, Gaosong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652714/
https://www.ncbi.nlm.nih.gov/pubmed/31124293
http://dx.doi.org/10.1111/jcmm.14338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652714/
https://www.ncbi.nlm.nih.gov/pubmed/31124293
http://dx.doi.org/10.1111/jcmm.14338

Ejemplares similares